Bosutinib-Teva 100 mg
Bosutinib-Teva 100 mg is a medicine authorised by Swissmedic under authorisation number 69223. The authorisation holder is Teva Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 28 May 2024 and the authorisation is limited until 27 May 2029. ATC code L01EA04 places the medicine in the group Antineoplastic agents.
| Authorisation number | 69223 |
|---|---|
| Name | Bosutinib-Teva 100 mg |
| Full name | Bosutinib-Teva 100 mg, Filmtabletten |
| Authorisation holder | Teva Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EA04 |
| First authorisation | 28 May 2024 |
| Authorisation validity | 27 May 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Bosutinib-Teva 100 mg, Filmtabletten | A | 28 May 2024 |
| 2 | Bosutinib-Teva 400 mg, Filmtabletten | A | 28 May 2024 |
| 3 | Bosutinib-Teva 500 mg, Filmtabletten | A | 28 May 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | L01EA04 | 07.16.1. | A |
| 2 | 28 | Tablette(n) | L01EA04 | 07.16.1. | A |
| 3 | 28 | Tablette(n) | L01EA04 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Bosutinib-Teva 100 mg authorised in Switzerland?
Yes. Bosutinib-Teva 100 mg is authorised by Swissmedic under authorisation number 69223, data as of 01 September 2026. The authorisation is limited until 27 May 2029.
Which dispensing category does Bosutinib-Teva 100 mg have?
Bosutinib-Teva 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Bosutinib-Teva 100 mg?
The authorisation holder is Teva Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.